Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-23-024971
Filing Date
2023-08-31
Accepted
2023-08-31 17:25:46
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A zvra20230831c_defa14a.htm DEFA14A 27453
2 EXHIBIT 99.1 ex_566486.htm EX-99.1 20705
  Complete submission text file 0001437749-23-024971.txt   49324
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36913 | Film No.: 231229803
SIC: 2834 Pharmaceutical Preparations